Scholarlink

<p>Atrial fibrillation (AF) affects approximately 1.6&#xa0;million people in Germany and represents the most common sustained cardiac arrhythmia, with the prevalence continuously rising due to demographic changes and increasing comorbidities. This comprehensive review article examines the current state of AF management in 2026, with particular emphasis on technological innovations, evidence-based treatment strategies and specific challenges within the German healthcare system. Modern AF management requires a&#xa0;differentiated, individualized approach integrating risk stratification, thromboembolism prophylaxis, heart rate or rhythm control and systematic treatment of comorbidities and cardiovascular risk factors. Early rhythm control has emerged as a&#xa0;central pillar demonstrating a significant reduction in cardiovascular events. Technological advances have fundamentally transformed AF management. Pulsed field ablation (PFA) represents a&#xa0;paradigm shift in electrophysiology, offering selective myocardial ablation with preservation of adjacent vulnerable structures. Dual-energy systems combining various ablation modalities provide enhanced procedural flexibility. Advanced diagnostic methods including wearables, implantable loop recorders and artificial intelligence-based electrocardiography (ECG) algorithms enable early detection of subclinical AF episodes and improved risk stratification. The progressive shift of electrophysiological procedures to outpatient settings represents one of the most important structural changes in German electrophysiology, creating new challenges and options for patients as well as the cross-sectoral medical care incorporating general practitioners up to specialist consultants (cardiologists and interventional electrophysiologists). Despite substantial progress, barriers remain including fragmentation of the healthcare system, reimbursement inadequacies, workforce shortages and regional disparities in provision of care. Future developments should prioritize personalization of treatment through advanced technologies, together with enhanced interdisciplinary networks and optimized patient care pathways.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Management von Vorhofflimmern 2026

  • 期刊论文

  • 发表日期：

    2026年2月26日

查看全文
  • Ilaria My,
  • Julia Vogler,
  • Arian Sultan,
  • Stephan Willems

摘要

Atrial fibrillation (AF) affects approximately 1.6 million people in Germany and represents the most common sustained cardiac arrhythmia, with the prevalence continuously rising due to demographic changes and increasing comorbidities. This comprehensive review article examines the current state of AF management in 2026, with particular emphasis on technological innovations, evidence-based treatment strategies and specific challenges within the German healthcare system. Modern AF management requires a differentiated, individualized approach integrating risk stratification, thromboembolism prophylaxis, heart rate or rhythm control and systematic treatment of comorbidities and cardiovascular risk factors. Early rhythm control has emerged as a central pillar demonstrating a significant reduction in cardiovascular events. Technological advances have fundamentally transformed AF management. Pulsed field ablation (PFA) represents a paradigm shift in electrophysiology, offering selective myocardial ablation with preservation of adjacent vulnerable structures. Dual-energy systems combining various ablation modalities provide enhanced procedural flexibility. Advanced diagnostic methods including wearables, implantable loop recorders and artificial intelligence-based electrocardiography (ECG) algorithms enable early detection of subclinical AF episodes and improved risk stratification. The progressive shift of electrophysiological procedures to outpatient settings represents one of the most important structural changes in German electrophysiology, creating new challenges and options for patients as well as the cross-sectoral medical care incorporating general practitioners up to specialist consultants (cardiologists and interventional electrophysiologists). Despite substantial progress, barriers remain including fragmentation of the healthcare system, reimbursement inadequacies, workforce shortages and regional disparities in provision of care. Future developments should prioritize personalization of treatment through advanced technologies, together with enhanced interdisciplinary networks and optimized patient care pathways.